Cytek Biosciences (CTKB) Return on Sales (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.0%, up from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q4 2024 and bottomed at 0.01% in Q4 2025.
• The 5-year median for Return on Sales is 0.0% (2025), against an average of 0.0%.
• The widest annual swing landed in 2022, when Return on Sales changed 0 bps; it then slipped 1 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then grew by 22 bps to 0.0% in 2023, then surged by 79 bps to 0.0% in 2024, then plunged by 523 bps to 0.01% in 2025, then jumped by 40 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison